ClinicalTrials.Veeva

Menu

Natural History and Biological Study of Netherton Syndrome (NSnatbio)

I

Institut National de la Santé Et de la Recherche Médicale, France

Status

Completed

Conditions

Healthy
Netherton Syndrome

Treatments

Other: Blood sample
Other: Biopsy

Study type

Interventional

Funder types

Other

Identifiers

NCT02081313
C12-56
2013-A00275-40 (Registry Identifier)

Details and patient eligibility

About

This study aims at studying the natural history of Netherton syndrome (NS), to identify the consequences of LEKTI deficiency on the immune system and to characterize new molecular mechanisms involved in the disease.

Enrollment

18 patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Adult or child (no age limit)
  • Confirmed diagnosis of Netherton syndrome
  • Signed informed consent form for the patient or his legal representative

Exclusion criteria

  • Bleeding disorder precluding skin biopsy

Trial design

18 participants in 2 patient groups

Netherton syndrome
Active Comparator group
Description:
Patients with Netherton syndrome
Treatment:
Other: Biopsy
Other: Blood sample
Healthy controls
Active Comparator group
Description:
healthy controls
Treatment:
Other: Biopsy
Other: Blood sample

Trial contacts and locations

1

Loading...

Central trial contact

Alain Hovnanian, MD, PhD; Laetitia Furio, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems